Plasma cell myeloma. An interpretive review (Q39921044)

15 September 2017

1 reference

title

Plasma cell myeloma. An interpretive review (English)

1 reference

10.1002/1097-0142(197212)30:6<1588::AID-CNCR2820300626>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197212)30:6%3C1588::AID-CNCR2820300626%3E3.0.CO;2-Y

5 February 2023

1 reference

10.1002/1097-0142(197212)30:6<1588::AID-CNCR2820300626>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197212)30:6%3C1588::AID-CNCR2820300626%3E3.0.CO;2-Y

5 February 2023

author name string

D. E. Bergsagel

1

1 reference

PubMed ID

4565818

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4565818

5 February 2023

language of work or name

English

0 references

publication date

1 December 1972

1 reference

PubMed ID

4565818

full work available at URL

15 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197212)30:6%3C1588::AID-CNCR2820300626%3E3.0.CO;2-Y

1 reference

10.1002/1097-0142(197212)30:6<1588::AID-CNCR2820300626>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197212)30:6%3C1588::AID-CNCR2820300626%3E3.0.CO;2-Y

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197212)30:6%3C1588::AID-CNCR2820300626%3E3.0.CO;2-Y

5 February 2023

1 reference

10.1002/1097-0142(197212)30:6<1588::AID-CNCR2820300626>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197212)30:6%3C1588::AID-CNCR2820300626%3E3.0.CO;2-Y

5 February 2023

1 reference

15 September 2017

30

1 reference

15 September 2017

6

1 reference

15 September 2017

1588-1594

1 reference

Melphalan and myeloma. Experience with a low-dose continuous regimen

15 September 2017

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197212%2930%3A6%3C1588%3A%3AAID-CNCR2820300626%3E3.0.CO%3B2-Y

Evaluation of chemical agents against the plasma cell tumor LPC-1 in mice

21 January 2018

1

1 reference

10.1002/1097-0142(197212)30:6<1588::AID-CNCR2820300626>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197212)30:6%3C1588::AID-CNCR2820300626%3E3.0.CO;2-Y

Metabolic balance investigation of three cases of multiple myeloma during ACTH administration; exchanges of calcium, phosphorus, nitrogen and electrolytes

5 February 2023

2

1 reference

10.1002/1097-0142(197212)30:6<1588::AID-CNCR2820300626>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197212)30:6%3C1588::AID-CNCR2820300626%3E3.0.CO;2-Y

The management of multiple myeloma

5 February 2023

3

1 reference

10.1002/1097-0142(197212)30:6<1588::AID-CNCR2820300626>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197212)30:6%3C1588::AID-CNCR2820300626%3E3.0.CO;2-Y

Combination chemotherapy for multiple myeloma

5 February 2023

5

1 reference

10.1002/1097-0142(197212)30:6<1588::AID-CNCR2820300626>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197212)30:6%3C1588::AID-CNCR2820300626%3E3.0.CO;2-Y

THE EFFECT OF PREDNISONE ON CALCIUM METABOLISM AND CA47 KINETICS IN PATIENTS WITH MULTIPLE MYELOMA AND HYPERCALCEMIA.

5 February 2023

7

1 reference

10.1002/1097-0142(197212)30:6<1588::AID-CNCR2820300626>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197212)30:6%3C1588::AID-CNCR2820300626%3E3.0.CO;2-Y

Total body irradiation for myelomatosis

5 February 2023

9

1 reference

10.1002/1097-0142(197212)30:6<1588::AID-CNCR2820300626>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197212)30:6%3C1588::AID-CNCR2820300626%3E3.0.CO;2-Y

The Treatment of Plasma Cell Myeloma

5 February 2023

13

1 reference

10.1002/1097-0142(197212)30:6<1588::AID-CNCR2820300626>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197212)30:6%3C1588::AID-CNCR2820300626%3E3.0.CO;2-Y

5 February 2023

16

28

2187

Bergsagel

1968

1 reference

10.1002/1097-0142(197212)30:6<1588::AID-CNCR2820300626>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197212)30:6%3C1588::AID-CNCR2820300626%3E3.0.CO;2-Y

Maximum utilization of the life table method in analyzing survival

5 February 2023

21

1 reference

10.1002/1097-0142(197212)30:6<1588::AID-CNCR2820300626>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197212)30:6%3C1588::AID-CNCR2820300626%3E3.0.CO;2-Y

On the effect of corticotropin (ACTH) on myelomatosis with special reference to the bone marrow and the serum proteins

5 February 2023

23

1 reference

10.1002/1097-0142(197212)30:6<1588::AID-CNCR2820300626>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197212)30:6%3C1588::AID-CNCR2820300626%3E3.0.CO;2-Y

Current Concepts in the Therapy of Multiple Myeloma

5 February 2023

24

1 reference

10.1002/1097-0142(197212)30:6<1588::AID-CNCR2820300626>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197212)30:6%3C1588::AID-CNCR2820300626%3E3.0.CO;2-Y

Growth rates and responses to treatment in human myelomatosis

5 February 2023

25

1 reference

10.1002/1097-0142(197212)30:6<1588::AID-CNCR2820300626>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197212)30:6%3C1588::AID-CNCR2820300626%3E3.0.CO;2-Y

The effect of hydrocortisone on immunoglobulin metabolism

5 February 2023

31

1 reference

10.1002/1097-0142(197212)30:6<1588::AID-CNCR2820300626>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197212)30:6%3C1588::AID-CNCR2820300626%3E3.0.CO;2-Y

5 February 2023

36

31

2116

Ogawa

1971

1 reference

10.1002/1097-0142(197212)30:6<1588::AID-CNCR2820300626>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197212)30:6%3C1588::AID-CNCR2820300626%3E3.0.CO;2-Y

The effects of adrenocortical hormones on albumin metabolism studied with albumin-I 131

5 February 2023

41

1 reference

10.1002/1097-0142(197212)30:6<1588::AID-CNCR2820300626>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197212)30:6%3C1588::AID-CNCR2820300626%3E3.0.CO;2-Y

Immunoglobulin synthesis and total body tumor cell number in IgG multiple myeloma

5 February 2023

43

1 reference

10.1002/1097-0142(197212)30:6<1588::AID-CNCR2820300626>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197212)30:6%3C1588::AID-CNCR2820300626%3E3.0.CO;2-Y

Clinical trials with N-isopropyl-alpha-(2-methylhydrazino)-p-toluamide hydrochloride in malignant lymphoma and other disseminated neoplasia

5 February 2023

46

1 reference

10.1002/1097-0142(197212)30:6<1588::AID-CNCR2820300626>3.0.CO;2-Y

https://api.crossref.org/works/10.1002/1097-0142(197212)30:6%3C1588::AID-CNCR2820300626%3E3.0.CO;2-Y

5 February 2023

Identifiers

10.1002/1097-0142(197212)30:6<1588::AID-CNCR2820300626>3.0.CO;2-Y

1 reference

15 September 2017

1 reference

PubMed ID

4565818